AI Summary
This grant opportunity (PAR-25-044) from NIH seeks to fund research into the mechanisms that impact cancer risk after bariatric surgery. Clinical trials are not allowed under this R21 funding mechanism. The CFDA numbers associated with this opportunity are 93.393, 93.396, and 93.399.